Single Molecule Analysis of MAGUK Structure and Ligand Binding

MAGUK 结构和配体结合的单分子分析

基本信息

  • 批准号:
    9884794
  • 负责人:
  • 金额:
    $ 44.49万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    2008
  • 资助国家:
    美国
  • 起止时间:
    2008-01-10 至 2023-03-31
  • 项目状态:
    已结题

项目摘要

This proposal focuses on post-synaptic glutamate signaling, which mediates excitatory neurotransmission. Glutamate receptor signaling is organized by the membrane-associated guanylate kinase (MAGuK) family of scaffold proteins. Scaffolds determine the outcome of signal transduction by controlling the location of neurotransmitter receptors and connecting them to downstream effectors. In particular, two homologous MAGuKs (PSD-95 and PSD-93) play opposing roles in synaptic plasticity yet the basis for their differential activity remains a mystery. A key factor in synaptic plasticity is post-translation modification (PTM) of the MAGuK proteins, which have been missing in most studies that have been published to date. This proposal investigates the posttranslational regulation of PSD-95 and PSD-93. Aim 1 will test the hypothesis that phosphorylation alters the structure and activity of MAGuKs. We propose that a difference in the number and location of PTM sites elicits activity differences. Aim 2 will test the hypothesis that palmitoylation, a lipid modification essential for synaptic targeting, alters MAGuK activity and coverts them into the filament observed at synapses. Studies to date focused on soluble proteins but palmitoylation is indispensable for activity. Aim 3 will test the hypothesis that phase transitions of MAGuKs regulate availability for receptor binding. SynGAP, an essential synaptic protein, induces to liquid phase separation of PSD-95. This can generate a dynamic “membrane-less organelle”. We will investigate the functional effects of phase separation on receptor binding and structure. We possess the only working reconstitution of scaffold interactions in the post-synapse and provided the only kinetic description of MAGuK scaffolding activity. We will use our unique expertise to address how PTM changes the activity of MAGuKs. We have pioneered novel methods for structural refinement of proteins containing intrinsic disorder and generated the only structural model of a full-length scaffold protein to date. We will use these approaches to provide a mechanistic understanding of how MAGuK structure affects scaffolding. Our published work suggests that proteins residing together on PSD-95 have “higher-order” interactions driven by the enforced proximity. Describing the molecular events in excitatory signaling is a fundamental challenge in neuroscience with direct relevance to brain development, memory and learning, and many neurological and neuropsychiatric disorders.
该提案重点关注突触后谷氨酸信号传导,它介导兴奋性 神经传递。谷氨酸受体信号传导是由膜相关的 鸟苷酸激酶 (MAGuK) 支架蛋白家族。支架决定结果 通过控制神经递质受体的位置和连接来进行信号转导 将它们传递给下游效应器。特别是,两种同源 MAGuK(PSD-95 和 PSD-93) 在突触可塑性中发挥相反的作用,但它们差异活动的基础仍然是 神秘。突触可塑性的一个关键因素是 MAGuK 的翻译后修饰 (PTM) 迄今为止已发表的大多数研究中都缺少蛋白质。 该提案研究了 PSD-95 和 PSD-93 的翻译后调控。目的 图 1 将检验磷酸化改变 MAGuK 的结构和活性的假设。我们 认为 PTM 位点数量和位置的差异会引起活性差异。 目标 2 将检验以下假设:棕榈酰化(一种突触必需的脂质修饰) 靶向、改变 MAGuK 活性并将其转化为在突触处观察到的细丝。 迄今为止的研究主要集中在可溶性蛋白质上,但棕榈酰化对于活性是必不可少的。目的 3 将检验 MAGuK 的相变调节受体可用性的假设 绑定。 SynGAP 是一种重要的突触蛋白,可诱导 PSD-95 的液相分离。 这可以产生动态的“无膜细胞器”。我们将调查功能 相分离对受体结合和结构的影响。 我们拥有突触后支架相互作用的唯一有效重建 并提供了 MAGuK 支架活性的唯一动力学描述。我们将用我们独特的 解决 PTM 如何改变 MAGuK 活动的专业知识。我们开创了小说 对含有内在无序的蛋白质进行结构精炼的方法,并产生了唯一的 迄今为止全长支架蛋白的结构模型。我们将使用这些方法来 提供对 MAGuK 结构如何影响脚手架的机械理解。我们发表的 研究表明,PSD-95 上共同存在的蛋白质具有“高阶”相互作用驱动 通过强制接近。描述兴奋信号传导中的分子事件是 神经科学中与大脑发育、记忆和记忆直接相关的基本挑战 学习以及许多神经系统和神经精神疾病。

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

Mark E Bowen其他文献

Mark E Bowen的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('Mark E Bowen', 18)}}的其他基金

Resolving the intoxication mechanism of botulinum neurotoxins using single molecule structural biology
利用单分子结构生物学解析肉毒杆菌神经毒素的中毒机制
  • 批准号:
    10717466
  • 财政年份:
    2023
  • 资助金额:
    $ 44.49万
  • 项目类别:
Single Molecule Analysis of MAGUK Structure and Ligand Binding
MAGUK 结构和配体结合的单分子分析
  • 批准号:
    10360516
  • 财政年份:
    2008
  • 资助金额:
    $ 44.49万
  • 项目类别:
SINGLE MOLECULE ANALYSIS OF PSD-95 STRUCTURE AND LIGAND BINDING
PSD-95 结构和配体结合的单分子分析
  • 批准号:
    7735586
  • 财政年份:
    2008
  • 资助金额:
    $ 44.49万
  • 项目类别:
SINGLE MOLECULE ANALYSIS OF PSD-95 STRUCTURE AND LIGAND BINDING
PSD-95 结构和配体结合的单分子分析
  • 批准号:
    7554662
  • 财政年份:
    2008
  • 资助金额:
    $ 44.49万
  • 项目类别:
SINGLE MOLECULE ANALYSIS OF PSD-95 STRUCTURE AND LIGAND BINDING
PSD-95 结构和配体结合的单分子分析
  • 批准号:
    7996650
  • 财政年份:
    2008
  • 资助金额:
    $ 44.49万
  • 项目类别:
Single Molecule Analysis of MAGUK Structure and Ligand Binding
MAGUK 结构和配体结合的单分子分析
  • 批准号:
    8370963
  • 财政年份:
    2008
  • 资助金额:
    $ 44.49万
  • 项目类别:
Single Molecule Analysis of MAGUK Structure and Ligand Binding
MAGUK 结构和配体结合的单分子分析
  • 批准号:
    8986207
  • 财政年份:
    2008
  • 资助金额:
    $ 44.49万
  • 项目类别:
SINGLE MOLECULE ANALYSIS OF PSD-95 STRUCTURE AND LIGAND BINDING
PSD-95 结构和配体结合的单分子分析
  • 批准号:
    8196939
  • 财政年份:
    2008
  • 资助金额:
    $ 44.49万
  • 项目类别:
Single Molecule Analysis of MAGUK Structure and Ligand Binding
MAGUK 结构和配体结合的单分子分析
  • 批准号:
    8606894
  • 财政年份:
    2008
  • 资助金额:
    $ 44.49万
  • 项目类别:

相似海外基金

Rational design of rapidly translatable, highly antigenic and novel recombinant immunogens to address deficiencies of current snakebite treatments
合理设计可快速翻译、高抗原性和新型重组免疫原,以解决当前蛇咬伤治疗的缺陷
  • 批准号:
    MR/S03398X/2
  • 财政年份:
    2024
  • 资助金额:
    $ 44.49万
  • 项目类别:
    Fellowship
CAREER: FEAST (Food Ecosystems And circularity for Sustainable Transformation) framework to address Hidden Hunger
职业:FEAST(食品生态系统和可持续转型循环)框架解决隐性饥饿
  • 批准号:
    2338423
  • 财政年份:
    2024
  • 资助金额:
    $ 44.49万
  • 项目类别:
    Continuing Grant
Re-thinking drug nanocrystals as highly loaded vectors to address key unmet therapeutic challenges
重新思考药物纳米晶体作为高负载载体以解决关键的未满足的治疗挑战
  • 批准号:
    EP/Y001486/1
  • 财政年份:
    2024
  • 资助金额:
    $ 44.49万
  • 项目类别:
    Research Grant
Metrology to address ion suppression in multimodal mass spectrometry imaging with application in oncology
计量学解决多模态质谱成像中的离子抑制问题及其在肿瘤学中的应用
  • 批准号:
    MR/X03657X/1
  • 财政年份:
    2024
  • 资助金额:
    $ 44.49万
  • 项目类别:
    Fellowship
CRII: SHF: A Novel Address Translation Architecture for Virtualized Clouds
CRII:SHF:一种用于虚拟化云的新型地址转换架构
  • 批准号:
    2348066
  • 财政年份:
    2024
  • 资助金额:
    $ 44.49万
  • 项目类别:
    Standard Grant
The Abundance Project: Enhancing Cultural & Green Inclusion in Social Prescribing in Southwest London to Address Ethnic Inequalities in Mental Health
丰富项目:增强文化
  • 批准号:
    AH/Z505481/1
  • 财政年份:
    2024
  • 资助金额:
    $ 44.49万
  • 项目类别:
    Research Grant
ERAMET - Ecosystem for rapid adoption of modelling and simulation METhods to address regulatory needs in the development of orphan and paediatric medicines
ERAMET - 快速采用建模和模拟方法的生态系统,以满足孤儿药和儿科药物开发中的监管需求
  • 批准号:
    10107647
  • 财政年份:
    2024
  • 资助金额:
    $ 44.49万
  • 项目类别:
    EU-Funded
BIORETS: Convergence Research Experiences for Teachers in Synthetic and Systems Biology to Address Challenges in Food, Health, Energy, and Environment
BIORETS:合成和系统生物学教师的融合研究经验,以应对食品、健康、能源和环境方面的挑战
  • 批准号:
    2341402
  • 财政年份:
    2024
  • 资助金额:
    $ 44.49万
  • 项目类别:
    Standard Grant
Ecosystem for rapid adoption of modelling and simulation METhods to address regulatory needs in the development of orphan and paediatric medicines
快速采用建模和模拟方法的生态系统,以满足孤儿药和儿科药物开发中的监管需求
  • 批准号:
    10106221
  • 财政年份:
    2024
  • 资助金额:
    $ 44.49万
  • 项目类别:
    EU-Funded
Recite: Building Research by Communities to Address Inequities through Expression
背诵:社区开展研究,通过表达解决不平等问题
  • 批准号:
    AH/Z505341/1
  • 财政年份:
    2024
  • 资助金额:
    $ 44.49万
  • 项目类别:
    Research Grant
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了